Brand / product

Erli Plus

Empagliflozin + Metformin · 12.5 mg + 850 mg

₨ Official source-observed price PKR 591.31 14's

PKR 42.24 / tablet

✓ Official DRAP price source observed · Source checked 2026-09-23

Price Intelligence

Equivalent price position

Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →

This brandPKR 42.24/ tablet

Price position11% below medianvs like-for-like peer median

Peer comparators20current-price listings

🔒

MedInfoBase Pharma Pro

Unlock the full competitive price benchmark

See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.

Rank & percentilePeer medianFull competitor listPortfolio intelligence

View Price Intelligence PRO

Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.

Product details

Generic: Empagliflozin + Metformin
Therapeutic area: Endocrine & metabolic
Drug class: Antidiabetic medicines
ATC: A10BA
Strength: 12.5 mg + 850 mg
Dosage form: Tablet
Pack: 14's
Registration no.: 114698
Price record verified: 2026-08-08
Latest DRAP source check: 2026-09-23 03:19

Manufacturer

PHARMEVO (PVT) LTD.

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →

Price movement

Official price over time

No change in the official DRAP price is recorded for this pack (14's). Current price PKR 591.31, effective 4 Aug 2025.

Cite this price history

MedInfoBase. Erli Plus 12.5 mg + 850 mg, 14's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/erli-plus-12-5-mg-850-mg-114698-14s-pharmevo-pvt-ltd-7909/ (accessed 24 September 2026).

Traceability

Official price history

Amount	Effective from	Verified	Source	Status
PKR 591.31	2025-08-04	2026-09-22	DRAP PharmaPrice Index (recovered from snapshot #84)	Current

Same generic

Other listed brands

Adrance-M 12.5 mg + 1000 mgAtco Laboratories Limited · PKR 1,659.57 Adrance-M 5 mg + 500 mgAtco Laboratories Limited · PKR 1,333.22 Adrance-M 5 mg + 850 mgAtco Laboratories Limited · PKR 356.00 Adrance-M 5 mg + 1000 mgAtco Laboratories Limited · PKR 1,402.44 Adrance-M 5 mg + 850 mgAtco Laboratories Limited · PKR 1,398.84 Adrance-M 12.5 mg + 850 mgAtco Laboratories Limited · PKR 1,655.96 Adrance-M 12.5 mg + 850 mgAtco Laboratories Limited · PKR 1,772.83 Adrance-M 12.5 mg + 500 mgAtco Laboratories Limited · PKR 832.48

Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.

Cite this record

Medicine record · DRAP registration 114698

MedInfoBase. (2026). Erli Plus 12.5 mg + 850 mg Tablet (14's), PHARMEVO (PVT) LTD. — registration and price record [Data set]. MedInfoBase. Retrieved September 24, 2026, from https://medinfobase.com/brand/erli-plus-12-5-mg-850-mg-114698-14s-pharmevo-pvt-ltd-7909/ Data observed 22 September 2026. Source: DRAP PharmaPrice Index (recovered from snapshot #84). DRAP registration 114698.

Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.